Pertussis in Latin America: Current situation and future vaccination challenges

Expert Review of Vaccines

Volumn 7, Issue 10, 2008, Pages 1569-1580

  Ulloa Gutierrez, Rolando ^a   Avila Aguero, María L ^b  

^a HOSPITAL NACIONAL DE NIÑOS   (Costa Rica)

^b Minister of Health of Costa Rica   (Costa Rica)

Author keywords

Adult; Bordetella pertussis; Caribbean; Central America; Children; Disease burden; Infant; Latin America; Morbidity; Mortality; South America

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ARGENTINA; BORDETELLA PERTUSSIS; BRAZIL; CHILE; COLOMBIA; COSTA RICA; DRUG INDICATION; HEALTH PROGRAM; HOSPITAL INFECTION; HUMAN; MEXICO; MORBIDITY; MORTALITY; OCCUPATIONAL HAZARD; PANAMA; PERTUSSIS; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; REVIEW; TREND STUDY; URUGUAY; VACCINATION;

CARIBBEAN REGION; CENTRAL AMERICA; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; PERTUSSIS VACCINE; SOUTH AMERICA; WHOOPING COUGH;

EID: 57549101404     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.7.10.1569     Document Type: Review

References (116)

1. WHO. Challenges in global immunization and the Global Immunization Vision and Strategy 2006-2015. Wkly Epidemiol. Rec. 81, 190-195 (2006).
2. Centers for Disease Control and Prevention (CDC). Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006-2015. MMWR Morb. Mortal. Wkly Rep. 55(18), 511-515 (2006).
3. Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis? Lancet Infect. Dis. 3, 413-418 (2003).
4. Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr. Infect. Dis. J. 24(5 Suppl.), S10-S18 (2005).
5. Halperin SA, Wang EE, Law B et al. Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program - Active (IMPACT). Clin. Infect. Dis. 28(6), 1238-1243 (1999). • Large, multicenter study of pertussis-related hospitalizations in 11 pediatric hospitals in Canada.
6. Skowronski DM, De Serres G, MacDonald D et al. The changing age and seasonal profile of pertussis in Canada. J. Infect. Dis. 185(10), 1448-1453 (2002).
7. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy TV. Trends in pertussis among infants in the United States, 1980-1999. JAMA 290(22), 2968-2975 (2003).
8. Elliott E, McIntyre P, Ridley G et al. National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatr. Infect. Dis. J. 23, 246-252 (2004).
9. Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE; EUVAC-NET Group. Resurgence of pertussis in Europe. Pediatr. Infect. Dis. J. 24, 761-765 (2005). • Describes the epidemiology of pertussis in western European countries. An increasing incidence was documented in selected groups.
10. Tozzi AE, Pandolfi E, Celentano LP et al. Comparison of pertussis surveillance systems in Europe. Vaccine 25, 291-729 (2007).
11. He Q, Mertsola J. Factors contributing to pertussis resurgence. Future Microbiol. 3, 329-339 (2008).
12. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Dis. J. 24(5 Suppl.), S58-S61 (2005).
13. Bisgard KM, Pascual FB, Ehresmann KR et al. Infant pertussis: who was the source? Pediatr. Infect. Dis. J. 23, 985-989 (2004).
14. Wendelboe AM, Njamkepo E, Bourillon A et al. Transmission of Bordetella pertussis to young infants. Pediatr. Infect. Dis. J. 26, 293-299 (2007).
15. Schellekens J, von König CH, Gardner P. Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr. Infect. Dis. J. 24, S19-S24 (2005).
16. Senzilet LD, Halperin SA, Spika JS et al. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin. Infect. Dis. 32(12), 1691-1697 (2001).
17. De Serres G, Shadmani R, Duval B et al. Morbidity of pertussis in adolescents and adults. J. Infect. Dis. 182, 174-179 (2000).
18. Somerville RL, Grant CC, Grimwood K et al. Infants hospitalised with pertussis: estimating the true disease burden. J. Paediatr. Child. Health 43, 617-622 (2007).
19. Ulloa-Gutierrez R, Hernández de Mezerville M, Avila-Agüero ML. Bordetella pertussis en Latinoamérica: estamos reconociendo el problema? An. Pediatr. (Barc.) 69, 197-199 (2008).
20. Wortis N, Strebel PM, Wharton M, Bardenheier B, Hardy IR. Pertussis deaths: report of 23 cases in the United States, 1992 and 1993. Pediatrics 97, 607-612 (1996).
21. Crowcroft NS, Andrews N, Rooney C, Brisson M, Miller E. Deaths from pertussis are underestimated in England. Arch. Dis. Child. 86, 336-338 (2002).
22. Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr. Infect. Dis. J. 22, 628-634 (2003).
23. Mikelova LK, Halperin SA, Scheifele D et al. Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada. J. Pediatr. 143, 576-581 (2003).
24. McEniery JA, Delbridge RG, Reith DM. Infant pertussis deaths and the management of cardiovascular compromise. J. Paediatr. Child. Health 40, 230-232 (2004).
25. Halasa NB, Barr FE, Johnson JE, Edwards KM. Fatal pulmonary hypertension associated with pertussis in infants: does extracorporeal membrane oxygenation have a role? Pediatrics 112, 1274-1278 (2003).
26. Pooboni S, Roberts N, Westrope C et al. Extracorporeal life support in pertussis. Pediatr. Pulmonol. 36, 310-315 (2003).
27. Goulin GD, Kaya KM, Bradley JS. Severe pulmonary hypertension associated with shock and death in infants infected with Bordetella pertussis. Crit. Care Med. 21, 1791-1794 (1993).
28. Namachivayam P, Shimizu K, Butt W. Pertussis: severe clinical presentation in pediatric intensive care and its relation to outcome. Pediatr. Crit. Care Med. 8, 207-211 (2007).
29. Surridge J, Segedin ER, Grant CC. Pertussis requiring intensive care. Arch. Dis. Child. 92, 970-975 (2007).
30. Romano MJ, Weber MD, Weisse ME, Siu BL. Pertussis pneumonia, hypoxemia, hyperleukocytosis, and pulmonary hypertension: improvement in oxygenation after a double volume exchange transfusion. Pediatrics 114, e264-e266 (2004).
31. Grzeszczak MJ, Churchwell KB, Edwards KM, Pietsch J. Leukopheresis therapy for severe infantile pertussis with myocardial and pulmonary failure. Pediatr. Crit. Care Med. 7, 580-582 (2006).
32. De Berry BB, Lynch JE, Chung DH, Zwischenberger JB. Pertussis with severe pulmonary hypertension and leukocytosis treated with extracorporeal membrane oxygenation. Pediatr. Surg. Int. 21, 692-694 (2005).
33. Forsyth K, Nagai M, Lepetic A, Trindade E. Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations. Pediatr. Infect. Dis. J. 24, S93-S97 (2005).
34. Expanded program on Immunization in the Americas. Pertussis outbreaks in the Americas. EPI Newsletter 20(1), 1-2 (1998).
35. Kowalzik F, Barbosa AP, Fernandes VR et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr. Infect. Dis. J. 26, 238-242 (2007).
36. Tomé Sandoval P, Torres Arreola LP, Romero Quechol G, Guiscafré Gallardo H. Bordetella pertussis en estudiantes adolescentes de la Ciudad de México. Rev. Saúde Pública 42, 679-683 (2008).
37. Navarrete-Navarro S, González-Romero M, Ruiz-Matus C, Casasola-Flores J. Estudio epidemiológico de un brote de tosferina en Rincón Grande, Veracrúz. Bol. Med. Hosp. Infant. Mex. 47, 304-312 (1990).
38. Sapián-López LA, Valdespino JL, Salvatierra B et al. Seroepidemiología de la tos ferina en México. Salud Pública Mex. 34, 177-185 (1992).
39. Secretaría de Salud Jalisco, Dirección General de Salud Pública, Departamento de Epidemiología. Boletín Mensual. Perfil clínico epidemiológico de las tosferina en Jalisco. 2(1), 2005.
40. th Annual Meeting of the Infectious Diseases Society of America. San Francisco, CA, USA 25-28 October 2001 (Abstract 283).
41. Herrera JF, Vargas A, Campos M, Marín JP, Moya T, Herrera ML. Immunofluorescencia por Bordetella pertussis Hospital Nacional de Niños. Rev. Med. Hosp. Nac. Niños (Costa Rica) 37, 33-39 (2002).
42. Paddock CD, Sanden GN, Cherry JD et al. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin. Infect. Dis. 47, 328-338 (2008). • Describes new pathologic findings in autopsies of infants who died of pertussis, which contribute to the understanding of the mechanisms leading to pulmonary hypertension and death.
43. Boza R, Ulloa-Gutierrez R, Garita K et al. Pertussis deaths in infants admitted to a pediatric intensive care unit (PICU) in Costa Rica. Presented at: 45th Annual Meeting of the Infectious Diseases Society of America. San Diego, CA, USA, 4-7 October, 2007 (Abstract 206).
44. Instituto Nacional de Salud de Colombia, Subdirección de Vigilancia y Control en Salud Pública. Bogotá, Colombia. Informe Quincenal Epidemiológico Nacional 11(5), 73-76 (2006).
45. Gonçalves CR, Vaz TMI, Medeiros MIC et al. Phenotypical and genotypical characterization of Bordetella pertussis strains isolated in São Paulo, Brazil, 1988-2002. Rev. Inst. Med. Trop. Sao Paulo 49, 123-125 (2007).
46. Baptista PN, Magalhães V, Rodrigues LC, Rocha MA, Pimentel AM. Source of infection in household transmission of culture-confirmed pertussis in Brazil. Pediatr. Infect. Dis. J. 24, 1027-1028 (2005).
47. de Oliveira e Silva RB, Lemes-Marques EG, Medeiros MIC et al. Diagnóstico laboratorial da coqueluche: freqüência do isolamento de Bordetella pertussis de amostras clínicas, por meio da técnica de cultura realizada nos laboratórios regionais do Instituto Adolfo Lutz, São Paulo, Brasil. Rev. Inst. Adolfo Lutz 66, 194-200 (2007).
48. Baptista PN, Magalhães V, Rodrigues LC, Rocha MW, Pimentel AM. Pertussis vaccine effectiveness in reducing clinical disease, transmissibility and proportion of cases with a positive culture after household exposure in Brazil. Pediatr. Infect. Dis. J. 25, 844-846 (2006).
49. Luz PM, Codeço CT, Werneck GL. A reemergência da coqueluche em países desenvolvidos: um problema também para Brasil? Cad. Saude Publica 19, 1209-1213 (2003).
50. Luz PM, Codeço CT, Werneck GL, Struchiner CJ. A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil. Epidemiol. Infect. 134, 850-862 (2006).
51. Baptista PN, Magalhães VS, Rodrigues LC. Children with pertussis inform the investigation of other pertussis cases among contacts. BMC Pediatr. 7, 21 (2007).
52. Trevizan S, Coutinho SE. Perfil epidemiológico da coqueluche no Rio Grande do Sul, Brasil: estudo da correlação entre incidência e cobertura vacinal. Cad. Saude Publica 24, 93-102 (2008).
53. Arnoni MV, Simoes CCN, Berezin EN. Bordetella pertussis infection in a pediatric hospital in Sao Paulo, Brazil: study of cases. Presented at: 26th Annual Meeting of the European Society for Paediatric Infectious Diseases. Graz, Austria, 13-17 May 2008.
54. Quian J, Cerisola A, Russomano F et al. Infecciones por Bordetella pertussis en niños menores de un año hospitalizados y sus contactos del hogar. Arch. Pediatr. Urug. 77, 229-236 (2006).
55. Quian J, Cerisola A, Fernández A, Russomano F. Infecciones respiratorias bajas mixtas por Bordetella pertussis y virus. Análisis de dos casos clínicos. Arch. Pediatr. Urug. 74, 278-281 (2003).
56. Sánchez I, Repetto G, Saenger A. Epidemiología de la tosferina en Chile, 1950-1990. El adulto, nuevo reservorio de infección? Rev. Med. Chil. 122, 339-345 (1994).
57. Wolff RM. Cambios epidemiológicos en las enfermedades infecciosas en Chile durante la década 1990-2000. Rev. Med. Chil. 130, 353-362 (2002).
58. Donoso FA, Wegner AA, León BJ, Ramírez AM, Carrasco OJA. Coqueluche en niños menores de seis meses de vida. Rev. Chil. Pediatr. 72, 334-339 (2001).
59. Donoso A, León J, Ramírez M, Rojas G, Oberpaur B. Pertussis and fatal pulmonary hypertension: a discouraged entity. Scand. J. Infect. Dis. 37, 145-148 (2005).
60. Donoso AF, Cruces PI, Camacho JF, León JA, Kong JA. Exchange transfusion to reverse severe pertussis-induced cardiogenic shock. Pediatr. Infect. Dis. J. 25, 846-848 (2006).
61. Riva Posse CA, Miceli IN. Evolución de la coqueluche en la Argentina a finales del siglo XX. Medicina (B. Aires) 65, 7-16 (2005).
62. Romano F, Quintana CB, de Daber MLS et al. Brote de coqueluche en Esquel. Arch. Argent. Pediatr. 100, 11-18 (2002).
63. Romanin V, Salvay MC, Man C, Mistchenko A, Gentile A. Brote de Bordetella pertussis en un hospital pediátrico. Rev. Hosp. Niños B. Aires 47, 211-216 (2005).
64. Gentile A, Lución MF, Salvay MC, Man C, Romanin V, Mistchenko A. Epidemiological pattern of Bordetella pertussis (BP) infection in a pediatric hospital. Presented at: 26th Annual Meeting of the European Society for Paediatric Infectious Diseases. Graz, Austria, 13-17 May 2008.
65. Fingermann M, Fernández J, Sisti F et al. Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production. Vaccine 24, 3513-3521 (2006).
66. Caro V, Bouchez V, Guiso N, Gatti B, Agosti MR, González Ayala SE. Pertussis in Argentina and France. Vaccine 25, 4335-4539 (2007).
67. Bottero D, Gaillard ME, Fingermann M et al. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin. Vaccine Immunol. 14, 1490-1498 (2007).
68. Hallander H, Advani A, Riffelmann M et al. Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis. J. Clin. Microbiol. 45, 3257-3262 (2007).
69. Elomaa A, Advani A, Donnelly D et al. Strain variation among Bordetella pertussis isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years. J. Clin. Microbiol. 43, 3681-3687 (2005).
70. Deeks S, De Serres G, Boulianne N et al. Failure of physicians to consider the diagnosis of pertussis in children. Clin. Infect. Dis. 28, 840-846 (1999). •• Reveals the importance of increasing the clinical suspicion and awareness of pertussis among physicians taking care of children.
71. Klass P. Index case. N. Engl. J. Med. 350, 2023-2026 (2004). •• Illustrative note reflecting how the diagnosis of pertussis can be missed by pediatric infectious disease specialists, even among physicians themselves.
72. Dworkin MS. Adults are whooping, but are internists listening? Ann. Intern. Med. 142, 832-835 (2005).
73. Ulloa-Gutierrez R, Boza R, Umaña MA et al. Parental unawareness, misconceptions, and poor knowledge about pertussis: a contributor to late or misdiagnosis in the developing world? Presented at: 44th Infectious Diseases Society of America's Annual Meeting. Toronto, ON, Canada, 12-15 October 2006 (Abstract 627).
74. Judelsohn RG, Koslap-Petraco MB. Public health perspectives on the rising incidence of pertussis. Public Health Nurs. 24, 421-428 (2007).
75. Ulloa-Gutierrez R. Pertussis mortality and public misperceptions. CMAJ 179, 492 (2008).
76. Murphy TV, Syed SB, Holman RC et al. Pertussis-associated hospitalizations in American Indian and Alaska Native infants. J. Pediatr. 152, 839-843 (2008).
77. de Quadros CA, Tambini G, DiFabio JL, Brana M, Santos JI. State of immunization in the Americas. Infect. Dis. Clin. North Am. 14, 241-257 (2000).
78. Andrus JK, Crouch AA, Fitzsimmons J, Vicari A, Tambini G. Immunization and the millennium development goals: progress and challenges in Latin America and the Caribbean. Health Aff. (Millwood) 27, 487-493 (2008).
79. Gangarosa EJ, Galazka AM, Wolfe CR et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 351, 356-361 (1998).
80. Le Saux N, Barrowman NJ, Moore DL et al. Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT. Pediatrics 112, e348 (2003).
81. Moore DL, Le Saux N, Scheifele D, Halperin SA; Members of the Canadian Paediatric Society/Health Canada Immunization Monitoring Program Active (IMPACT). Lack of evidence of encephalopathy related to pertussis vaccine: active surveillance by IMPACT, Canada, 1993-2002. Pediatr. Infect. Dis. J. 23, 568-571 (2004).
82. Ray P, Hayward J, Michelson D, Lewis E et al. Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study. Pediatr. Infect. Dis. J. 25, 768-773 (2006).
83. Bettinger JA, Halperin SA, De Serres G, Scheifele DW, Tam T. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada. Pediatr. Infect. Dis. J. 26, 31-35 (2007). • Demonstrates how the change from whole-cell to acellular pertussis vaccines in Canada was associated with lower rates of pediatrics hospitalizations due to pertussis.
84. Ward JI, Cherry JD, Chang SJ et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N. Engl. J. Med. 353, 1555-1563 (2005).
85. Halperin SA. Canadian experience with implementation of an acellular pertussis vaccine booster-dose program in adolescents: implications for the United States. Pediatr. Infect. Dis. J. 24, S141-S146 (2005).
86. Forsyth KD, Campins-Marti M, Caro J et al. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. Clin. Infect. Dis. 39, 1802-1809 (2004).
87. Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 25, 2634-2642 (2007). •• Expert position paper addressing the latest recommendations and best strategies to fight against pertussis, including vaccination for selected target populations.
88. Wirsing von König CH, Campins-Marti M, Finn A, Guiso N, Mertsola J, Liese J. Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations. Pediatr. Infect. Dis. J. 24, S87-S92 (2005).
89. Tan T, Halperin S, Cherry JD et al. Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerations. Pediatr. Infect. Dis. J. 24, S83-S86 (2005).
90. American Academy of Pediatrics Commitee on Infectious Diseases. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics 117, 965-978 (2006).
91. Kretsinger K, Broder KR, Cortese MM et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm. Rep. 55, 1-37 (2006).
92. Murphy TV, Slade BA, Broder KR et al. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 57, 1-51 (2008). •• Most recently updated guidelines from the Advisory Committee on Immunization Practices discussing the best evidence-based recommendations for vaccinating pregnant and postpartum women with the combined tetanus, diphtheria and pertussis vaccine to protect young infants from acquiring pertussis.
93. Gidengil CA, Sandora TJ, Lee GM. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA. Expert Rev. Vaccines 7, 621-634 (2008).
94. Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards KM, Baker CJ. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J. Infect. Dis. 190, 335-340 (2004).
95. Healy CM, Baker CJ. Prospects for prevention of childhood infections by maternal immunization. Curr. Opin. Infect. Dis. 19, 271-276 (2006).
96. Edwards KM. Pertussis: an important target for maternal immunization. Vaccine 21, 3483-3486 (2003).
97. Mooi FR, de Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect. Dis. 7, 614-624 (2007).
98. Belloni C, De Silvestri A, Tinelli C et al. Immunogenicity of a three-component acellular pertussis vaccine administered at birth. Pediatrics 111, 1042-1045 (2003).
99. Halasa NB, O'Shea A, Shi JR, Lafleur BJ, Edwards KM. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J. Pediatr. 153, 327-332 (2008).
100. Knuf M, Schmitt HJ, Wolter J et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J. Pediatr. 152, 655-660 (2008).
101. Edwards KM, Talbot TR. The challenges of pertussis outbreaks in healthcare facilities: is there a light at the end of the tunnel? Infect. Control. Hosp. Epidemiol. 27, 537-540 (2006).
102. Faruque MO, Senanayake S, Meyer AD, Dear KB. Emergency department staff and susceptibility to pertussis: a seroprevalence study. Emerg. Med. Australas. 20, 45-50 (2008).
103. Peadon E, Cooper C. Whooping cough: are health-care workers putting children at risk? J. Paediatr. Child Health 43, 398-402 (2007).
104. Littmann M, Hülsse C, Riffelmann M, Wirsing von König CH. Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric health-care workers. Vaccine 26, 2344-2349 (2008).
105. Sandora TJ, Gidengil CA, Lee GM. Pertussis vaccination for health care workers. Clin. Microbiol. Rev. 21, 426-434 (2008).
106. Calugar A, Ortega-Sánchez IR, Tiwari T, Oakes L, Jahre JA, Murphy TV. Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers. Clin. Infect. Dis. 42, 981-988 (2006).
107. Goins WP, Schaffner W, Edwards KM, Talbot TR. Healthcare workers' knowledge and attitudes about pertussis and pertussis vaccination. Infect. Control Hosp. Epidemiol. 28, 1284-1289 (2007).
108. Shah S, Caprio M, Mally P, Hendricks-Munoz K. Rationale for the administration of acellular pertussis vaccine to parents of infants in the neonatal intensive care unit. J. Perinatol. 27(1), 1-3 (2007).
109. Schuchat A, Bell BP. Monitoring the impact of vaccines postlicensure: new challenges, new opportunities. Expert Rev. Vaccines 7(4), 437-456 (2008).
110. World Health Organization www.who.int/vaccines-documents/GlobalSummary/ GlobalSummary.pdf
111. PubMed www.ncbi.nlm.nih.gov/sites/entrez
112. Biblioteca Virtual en Salud www.bireme.br
113. Panamerican Health Organization www.paho.org
114. World Health Organization http://amro.who.int/english/ad/fch/im/ Pertussis_NumberCases.pdf (Accessed 19 July 2008)
115. Revista Pediatría Electrónica. Muñoz Bonilla P, Miranda Olivares JP, Bueno B, Hernández Araya E. Coqueluche, hemograma y manifestaciones radiológicas en menores de 6 meses. XLII Jornadas de Investigación Pediátrica, Santiago Norte 2007, Chile www.revistapediatria.cl/vol4num3/resumen13.html
116. WHO International. Immunization coverage with DTP3 vaccines in infants, 2006 www.who.int/immunization_monitoring/diseases/dtp3_map_coverage.jpg